221 related articles for article (PubMed ID: 28984649)
1. Orthostatic hypotension for the cardiologist.
Mar PL; Raj SR
Curr Opin Cardiol; 2018 Jan; 33(1):66-72. PubMed ID: 28984649
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
Olshansky B; Muldowney J
Am J Cardiol; 2020 May; 125(10):1582-1593. PubMed ID: 32204870
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
Isaacson SH; Skettini J
Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
[TBL] [Abstract][Full Text] [Related]
4. New developments in the management of neurogenic orthostatic hypotension.
Biaggioni I
Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
[TBL] [Abstract][Full Text] [Related]
5. A practical guide to the treatment of neurogenic orthostatic hypotension.
Berger MJ; Kimpinski K
Can J Neurol Sci; 2014 Mar; 41(2):156-63. PubMed ID: 24534025
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.
Patrick K; Martin T
JBI Database System Rev Implement Rep; 2017 Sep; 15(9):2287-2294. PubMed ID: 28902695
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
8. Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Cheshire WP
Expert Opin Pharmacother; 2019 Feb; 20(2):187-199. PubMed ID: 30376728
[TBL] [Abstract][Full Text] [Related]
9. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
Kremens D; Lew M; Claassen D; Goodman BP
Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
[No Abstract] [Full Text] [Related]
10. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K
Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
[TBL] [Abstract][Full Text] [Related]
11. Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
[TBL] [Abstract][Full Text] [Related]
12. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
Mobarek SK
BMC Cardiovasc Disord; 2020 Feb; 20(1):54. PubMed ID: 32019498
[TBL] [Abstract][Full Text] [Related]
13. Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Goodman BP; Claassen D; Mehdirad A
Clin Auton Res; 2017 Jul; 27(Suppl 1):17-19. PubMed ID: 28631223
[No Abstract] [Full Text] [Related]
14. Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy.
Goodman BP; Gupta F
Clin Auton Res; 2017 Jul; 27(Suppl 1):21-23. PubMed ID: 28631222
[No Abstract] [Full Text] [Related]
15. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
Loavenbruck A; Sandroni P
Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic Hypotension: A Practical Approach.
Kim MJ; Farrell J
Am Fam Physician; 2022 Jan; 105(1):39-49. PubMed ID: 35029940
[TBL] [Abstract][Full Text] [Related]
17. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
Ho AH; Kinter CW; Wight J; Neelam AR; Krakow D
J Med Case Rep; 2020 Jun; 14(1):73. PubMed ID: 32560740
[TBL] [Abstract][Full Text] [Related]
18. Droxidopa in neurogenic orthostatic hypotension.
Kaufmann H; Norcliffe-Kaufmann L; Palma JA
Expert Rev Cardiovasc Ther; 2015; 13(8):875-91. PubMed ID: 26092297
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data.
François C; Hauser RA; Aballéa S; Dorey J; Kharitonova E; Hewitt LA
J Med Econ; 2016; 19(5):515-25. PubMed ID: 26710315
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.
Vernino S; Claassen D
Clin Auton Res; 2017 Jul; 27(Suppl 1):33-34. PubMed ID: 28674868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
